Today's Rundown Novartis strikes $9.7B takeover of The Medicines Company Ferring, Blackstone spin out gene therapy with $570M in funding Harvard, MIT spearhead $50M manufacturing center to speed cell, gene therapy R&D [Sponsored] How life sciences brands can win on mobile, right now U.K. government vows to double dementia funding if reelected Asuragen, Wave Life Sciences partner for Huntington's diagnostics deal Featured Story | | | Monday, November 25, 2019 Novartis has agreed to a $9.7 billion (€8.8 billion) deal to buy The Medicines Company for inclisiran. The takeover represents a big bet that the near-approval cholesterol drug will perform better commercially than rival medicines sold by Amgen and Regeneron and Sanofi. |
|
|---|
|
Top Stories Monday, November 25, 2019 Ferring Pharmaceuticals has spun out its late-phase gene therapy nadofaragene firadenovec with the support of Blackstone Life Sciences. The two organizations have put up $570 million to support the spinout as it works to bring the bladder cancer drug to the U.S. and other markets. Monday, November 25, 2019 Cell and gene therapies hold promise in many diseases but researchers working in the space can be held up by a manufacturing bottleneck. Harvard University and MIT are working to change that; with other Massachusetts life sciences players, the universities are setting up a new manufacturing center, slated to open in 2021. Monday, November 25, 2019 Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story. Monday, November 25, 2019 The incumbent U.K. prime minister has vowed to double spending on dementia research if his party is elected to form the next government. The spending plan will amount to an extra £83 million ($107 million) a year. Monday, November 25, 2019 Molecular diagnostics company Asuragen is teaming up with biotech Wave Life Sciences to help develop a new diagnostic for its experimental Huntington’s disease therapy. Enrollment Showcase | | | Sponsored by: University of Florida College of Pharmacy University of Florida precision medicine leaders highlight current knowledge and trends to advance the future of health care in this new webinar series. Register today. |
|
|---|
|
Resources Sponsored by: Catalent Pharma Solutions In this Q&A, four Catalent Biologics experts share how scale-up, regulatory expectations, demand forecasting and process validation all play a role in the success of a biologic when embarking upon the commercial manufacturing journey. Sponsored by: Amazon Web Services From IoT to data management to high-performance computing and machine learning, leading life sciences organizations are using Amazon Web Services (AWS) to develop scalable, global, predictable, and secure solutions to modernize clinical trials while mitigating risks Sponsored by: Outer Edge Technology, LLC See why visionaries outsource the design and management of the infrastructure allowing their scientists to innovate. Sponsored by: Veeva Systems Medical Affairs 2025 brings together leading perspectives from AstraZeneca, Bristol-Myers Squibb, Merck, Lilly, and other innovative life sciences organizations on key challenges impacting medical affairs and a roadmap for success in the coming decade. Sponsored by: SHYFT Analytics This whitepaper provides a snapshot of where the biopharma industry is now, where it's heading, and how companies are allocating their resources to adapt & grow. Sponsored by: IBM Watson Health IBM’s highlighted solutions reside in a security-rich cloud environment—home for capturing, managing and analyzing clinical study data with control, accuracy and confidence. These solutions lay the groundwork for further integration with IBM® Watson® cognitive technology. Sponsored by: IBM Watson Health Inpatient View and Outpatient View are powered by robust data assets and use sophisticated projection methodologies to help ensure accuracy of reporting. Sponsored by: IBM Watson Health Acknowledging various stakeholder networks, as well as recognizing variances within the regulatory environment, we believe, is essential for companies looking to uncover the right decision-makers in support of biologics or biosimilars. Learn more. Sponsored by: ON24 Discover solutions to the most common challenges faced by medical device companies. Sponsored by: Eli Lilly and Company in partnership with Xcenda Download this complimentary paper that explores the practice of step therapy and its impact on key stakeholders in the US healthcare system. Sponsored by: Clarivate Analytics 18 high-value new licensing deals worth in excess of $500 million took place during the second quarter of 2019 -Get the Q2 2019 Biopharma licensing report for full details and insights. Sponsored by: Patheon, by Thermo Fisher Scientific Is your API development on track? Sponsored by: BBK Worldwide Get the latest data on how people are using apps to manage their health, and learn how you can leverage it in the development of your next clinical trial app. Sponsored by: Blue Latitude Health Report: How to design digital services that deliver value and improve outcomes for patients, healthcare professionals and the healthcare systems they serve Sponsored by: Article Galaxy powered by Reprints Desk This white paper examines the skyrocketing cost of drug development and provides step-by-step guidance for executing a successful fail fast strategy. Sponsored by: Roche and IQVIA A global landscape study of funding trends and innovations. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. FierceBiotech Executive Breakfast at the J.P. Morgan Healthcare Conference 2020 January 14, 2020 | The Fairmont Hotel | San Francisco, CA 4th Annual Gene Therapy for Rare Disorders March 30 – April 2, 2020 | Boston, MA A Rare Affair for Rare Diseases January 12, 2020 | San Francisco, CA | 